Abstract
As a member of the S100 protein family, S100A11 expression is often upregulated in human cancer tissues. Numerous studies have demonstrated that S100A11 plays an important role in the progression of cancer. However, the function of S100A11 in ovarian cancer remains elusive. In the present study, the expression levels of S100A11 were found to be significantly increased in ovarian cancer cells. Subsequently, the expression of S100A11 in ovarian cancer HO8910 cells was knocked down using short hairpin (sh)RNA in order to investigate the biological effects of S100A11 on the progression of the disease. The results demonstrated that knockdown of S100A11 by shRNA inhibited the proliferation, anchorage-independent growth, invasion and migration of HO8910 cells. In addition, knockdown of S100A11 increased the expression of E-cadherin and decreased the expression of Snail in HO8910 cells. Collectively, these results indicated that S100A11 was able to promote the growth, invasion and migration of ovarian cancer cells. Therefore, S100A11 may serve as a potential molecular target for the diagnosis and treatment of ovarian cancer.
References
Apr 1, 1996·Trends in Biochemical Sciences·B W Schäfer, C W Heizmann
May 7, 2002·Frontiers in Bioscience : a Journal and Virtual Library·Claus W HeizmannBeat W Schäfer
Jun 19, 2004·Cancer Research·Masahiro MiyazakiNam-Ho Huh
Jun 15, 2007·Pathology·Marcello GuarinoGianmario Ballabio
Aug 30, 2008·Cellular and Molecular Life Sciences : CMLS·F van Roy, G Berx
Dec 18, 2009·Current Drug Targets·D GalloG Scambia
Mar 6, 2010·Oncology Reports·Lin GanYinkun Liu
Sep 28, 2010·Amino Acids·Masakiyo Sakaguchi, Nam-ho Huh
Dec 15, 2010·Tumour Biology : the Journal of the International Society for Oncodevelopmental Biology and Medicine·Eadaoin McKiernanMichael J Duffy
Aug 24, 2011·Molecular and Cellular Biochemistry·Juanting HaoDacheng He
Sep 14, 2011·Medical Oncology·Ming-Bing XiaoRun-Zhou Ni
Mar 21, 2012·The Journal of Pathology·Stephan MedingAxel Walch
Jun 26, 2012·Cancer Metastasis Reviews·Rémi LonguespéeMichel Salzet
Jul 19, 2012·Journal of Cellular Biochemistry·Li-Na WangYi-Xuan Yang
Mar 14, 2013·Progress in Molecular Biology and Translational Science·Alexander Gheldof, Geert Berx
Aug 10, 2013·The Journal of Clinical Endocrinology and Metabolism·Maria Chiara AnaniaAngela Greco
Sep 21, 2013·International Journal of Medical Sciences·Chengyu WangShuwei Zhao
Nov 28, 2013·Journal of Molecular Medicine : Official Organ of the Gesellschaft Deutscher Naturforscher Und Ärzte·Ziqiang LiYuquan Wei
Jan 1, 2014·PloS One·Xiaoying LuoZonghai Li
Jan 9, 2014·CA: a Cancer Journal for Clinicians·Rebecca SiegelAhmedin Jemal
Feb 1, 2014·International Journal of Molecular Medicine·Yi-Fei JiMing-Bing Xiao
May 9, 2014·Nature Communications·Jyoti K JaiswalJesper Nylandsted
Citations
Mar 24, 2018·Future Oncology·Meixia ZhangBoheng Zhang
May 18, 2017·Tumour Biology : the Journal of the International Society for Oncodevelopmental Biology and Medicine·Lin LiuHaitao Zhu
Sep 6, 2018·Molecular Carcinogenesis·Mei-Xia ZhangShuang-Jian Qiu
Jan 30, 2018·Oncology Letters·Mingbing XiaoRunzhou Ni
Sep 30, 2020·Breast Cancer : the Journal of the Japanese Breast Cancer Society·Kanchan KumariSandip K Mishra
Aug 21, 2019·Journal of Cellular and Molecular Medicine·Yiming TuJing Ji
May 27, 2016·The Journal of Biological Chemistry·Yen-Kai HuangChin Yu
Apr 30, 2019·Cancer Biomarkers : Section a of Disease Markers·Nan MaYingzhuan Zhan
Nov 18, 2015·Applied Immunohistochemistry & Molecular Morphology : AIMM·Yanli Li, Jiarong Zhang
Mar 26, 2021·BioMed Research International·Wenjing LiXiangyu Wang
Apr 28, 2021·Technology in Cancer Research & Treatment·Haopeng WangHongwei Cheng
May 2, 2021·Cancer Cell International·Yuxin CuiWen G Jiang
Jun 29, 2021·Frontiers in Cell and Developmental Biology·Linqiang ZhangBin Liang
Aug 29, 2019·ACS Omega·Deepu DowarhaChin Yu
Oct 17, 2021·Bioengineered·Yuan GaoWen Yang